Contact
Have a question or want to discuss solutions?
Send us a note
Fill out the form and a representative will be in touch shortly. You can also email us directly.
What happens next
How a conversation usually goes
Nothing here commits you to anything. Each step exists so the next one is worth having.
- 1
Non-confidential overview
We send the presentation copy that carries no confidential material, so your team can circulate it internally without paperwork.
- 2
Mutual NDA
A two-way agreement, so both sides can put real formulation and roadmap detail on the table.
- 3
In-depth data review
Safety testing, dosage delivery, SPF results, and cell response data, reviewed with your formulators and regulatory people in the room.
- 4
Scope the work
Target products, claim language, and markets. That becomes the statement of work for Phase I.